Loading
Yanuki
ARTICLE DETAIL
Flu Vaccine Effectiveness and COVID-19 Vaccine Sales Decline | Femtech Market Growth to $26 Billion by 2033: Key Insights and Opportunities | Preparing for Daylight Saving Time 2026: What You Need to Know | Oscar-Nominated Directors Highlight Workers at a Women's Health Clinic in 'The Devil Is Busy' | Trump Spotted with Rash on Neck: Possible Causes and Theories | Olympic Village Condom Shortage: A Hot Topic at the 2026 Winter Games | Talcum Powder and Cancer: Unveiling the Connection | Drug-Resistant Typhoid Fever: An Ancient Killer Returns | RFK Jr.'s CDC Panel to Discuss Covid Vaccine Injuries | Flu Vaccine Effectiveness and COVID-19 Vaccine Sales Decline | Femtech Market Growth to $26 Billion by 2033: Key Insights and Opportunities | Preparing for Daylight Saving Time 2026: What You Need to Know | Oscar-Nominated Directors Highlight Workers at a Women's Health Clinic in 'The Devil Is Busy' | Trump Spotted with Rash on Neck: Possible Causes and Theories | Olympic Village Condom Shortage: A Hot Topic at the 2026 Winter Games | Talcum Powder and Cancer: Unveiling the Connection | Drug-Resistant Typhoid Fever: An Ancient Killer Returns | RFK Jr.'s CDC Panel to Discuss Covid Vaccine Injuries

Health / Vaccines

Flu Vaccine Effectiveness and COVID-19 Vaccine Sales Decline

This article summarizes key findings from recent studies on flu vaccine effectiveness and reports on the declining sales of Pfizer's COVID-19 vaccine, providing an overview of current trends in vaccine usage and public health recommendation...

Analyses: High-dose flu vaccine better protects against hospitalization, infection than standard-dose
Share
X LinkedIn

vaccines
Flu Vaccine Effectiveness and COVID-19 Vaccine Sales Decline Image via CIDRAP

Key Insights

  • High-dose influenza vaccines (HD-IIV) are more effective than standard-dose vaccines (SD-IIV) in preventing hospitalization and infection in older adults.
  • A study showed HD-IIV was 40% more effective against hospitalization for flu or pneumonia compared to SD-IIV.
  • Another study indicated that HD-IIV provided 29% greater protection against lab-confirmed influenza episodes in older adults, especially those aged 80 and older.
  • Pfizer's Comirnaty COVID-19 vaccine sales in the U.S. dropped by 25% due to narrowed recommendations from federal regulators.
  • Declining interest in COVID-19 shots is attributed to anti-vaccine sentiment and confusion about the necessity of boosters.

In-Depth Analysis

Two new analyses provide evidence supporting the use of high-dose flu vaccines for older adults. The first study, published in *The Lancet*, revealed that vaccinating 515 older adults with HD-IIV instead of SD-IIV could prevent one all-cause hospitalization. The second study, published in the *International Journal of Infectious Diseases*, found that Italian older adults receiving HD-IIV reported fewer lab-confirmed influenza cases compared to those vaccinated with SD-IIV.

Meanwhile, Pfizer reported a 25% decrease in U.S. sales of its Comirnaty COVID-19 vaccine. This decline is attributed to revised recommendations from the CDC, which now leave the decision to get vaccinated up to individual patients. Experts suggest that anti-vaccine sentiment and confusion about the necessity of boosters contribute to the reduced demand. The change in government guidance has also raised questions about insurance coverage, though major industry groups have clarified that the shots will continue to be covered.

Pharmacy owners note increased confusion among customers, with many expressing uncertainty about who to believe regarding vaccine information. This confusion, coupled with declining infection rates for COVID-19, has led to a significant drop in sales for both Pfizer's vaccine and its COVID-19 treatment, Paxlovid.

Read source article

FAQ

Are high-dose flu vaccines more effective?

Yes, studies show high-dose flu vaccines provide better protection against hospitalization and infection in older adults compared to standard-dose vaccines.

Why are COVID-19 vaccine sales declining?

Factors include narrowed recommendations from health authorities, anti-vaccine sentiment, confusion about booster necessity, and declining infection rates.

Takeaways

  • Older adults should consider high-dose flu vaccines for better protection against influenza.
  • Stay informed about current vaccine recommendations from reliable sources like the CDC &ref=yanuki.com to make informed health decisions.
  • Be aware that insurance coverage for COVID-19 vaccines is generally maintained despite guideline changes.

Discussion

Do you think high-dose flu vaccines should be the standard for older adults? How has the changing guidance affected your decision to get vaccinated against COVID-19? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.